{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:03:39Z","timestamp":1784765019468,"version":"3.55.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.cld.2026.04.005","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T11:49:42Z","timestamp":1779709782000},"page":"657-675","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Genetic Cholestasis Syndromes"],"prefix":"10.1016","volume":"30","author":[{"given":"Eliza","family":"Flanagan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natassia Pinpin","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1 Suppl","key":"10.1016\/j.cld.2026.04.005_bib1","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/j.jhep.2015.02.025","article-title":"Genetics of liver disease: from pathophysiology to clinical practice","volume":"62","author":"Karlsen","year":"2015","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.cld.2026.04.005_bib2","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1002\/hep.30826","article-title":"Exome sequencing in clinical hepatology","volume":"70","author":"Vilarinho","year":"2019","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.cld.2026.04.005_bib3","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1002\/hep.32437","article-title":"Cholestatic liver diseases of genetic etiology: Advances and controversies","volume":"75","author":"Ibrahim","year":"2022","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.cld.2026.04.005_bib4","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.jhep.2019.01.036","article-title":"Clinical utility of genomic analysis in adults with idiopathic liver disease","volume":"70","author":"Hakim","year":"2019","journal-title":"J Hepatol"},{"issue":"10","key":"10.1016\/j.cld.2026.04.005_bib5","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1002\/hep4.2051","article-title":"Clinical phenotype of adult-onset liver disease in patients with variants in ABCB4, ABCB11, and ATP8B1","volume":"6","author":"Nayagam","year":"2022","journal-title":"Hepatol Commun"},{"issue":"4","key":"10.1016\/j.cld.2026.04.005_bib6","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.cgh.2025.07.031","article-title":"Diagnostic yield of whole exome sequencing in adult-onset cholestatic liver disease","volume":"24","author":"Scaravaglio","year":"2026","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2026.04.005_bib7","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.cld.2012.12.002","article-title":"Genetic determinants of cholestasis","volume":"17","author":"Hirschfield","year":"2013","journal-title":"Clin Liver Dis"},{"issue":"1","key":"10.1016\/j.cld.2026.04.005_bib8","article-title":"Challenges in the diagnosis and treatment of genetic cholestasis in adults","volume":"8","author":"Thompson","year":"2026","journal-title":"JHEP Rep"},{"issue":"1","key":"10.1016\/j.cld.2026.04.005_bib9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jceh.2013.10.005","article-title":"Progressive familial intrahepatic cholestasis","volume":"4","author":"Srivastava","year":"2014","journal-title":"J Clin Exp Hepatol"},{"issue":"Suppl 1","key":"10.1016\/j.cld.2026.04.005_bib10","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/S2210-7401(12)70018-9","article-title":"Progressive familial intrahepatic cholestasis","volume":"36","author":"Jacquemin","year":"2012","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"2","key":"10.1016\/j.cld.2026.04.005_bib11","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0168-8278(99)80240-2","article-title":"Genetic basis of progressive familial intrahepatic cholestasis","volume":"31","author":"Jacquemin","year":"1999","journal-title":"J Hepatol"},{"issue":"7","key":"10.1016\/j.cld.2026.04.005_bib12","doi-asserted-by":"crossref","DOI":"10.4254\/wjh.v17.i7.108253","article-title":"New hope in treating progressive familial intrahepatic cholestasis in children","volume":"17","author":"Mkarem","year":"2025","journal-title":"World J Hepatol"},{"issue":"4","key":"10.1016\/j.cld.2026.04.005_bib13","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cld.2018.06.003","article-title":"Progressive familial intrahepatic cholestasis","volume":"22","author":"Bull","year":"2018","journal-title":"Clin Liver Dis"},{"issue":"1","key":"10.1016\/j.cld.2026.04.005_bib14","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.clinre.2018.07.010","article-title":"Systematic review of progressive familial intrahepatic cholestasis","volume":"43","author":"Baker","year":"2019","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.cld.2026.04.005_bib15","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2147\/HMER.S137209","article-title":"Progressive familial intrahepatic cholestasis: diagnosis, management, and treatment","volume":"10","author":"Gunaydin","year":"2018","journal-title":"Hepat Med"},{"key":"10.1016\/j.cld.2026.04.005_bib16","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3389\/fphys.2016.00275","article-title":"P4-ATPases as phospholipid flippases-structure, function, and enigmas","volume":"7","author":"Andersen","year":"2016","journal-title":"Front Physiol"},{"issue":"2","key":"10.1016\/j.cld.2026.04.005_bib17","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jhep.2024.04.006","article-title":"EASL Clinical Practice Guidelines on genetic cholestatic liver diseases","volume":"81","year":"2024","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2026.04.005_bib18","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/hep.31787","article-title":"Impact of genotype, serum bile acids, and surgical biliary diversion on native liver survival in FIC1 deficiency","volume":"74","author":"van Wessel","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2026.04.005_bib19","first-page":"1","article-title":"Enigmatic functions of ATP8B1: cholestasis, inflammation, phosphoinositide flipping, and cellular homeostasis","author":"Prince","year":"2025","journal-title":"Cell Cycle"},{"issue":"1","key":"10.1016\/j.cld.2026.04.005_bib20","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/hep.20285","article-title":"Characterization of mutations in ATP8B1 associated with hereditary cholestasis","volume":"40","author":"Klomp","year":"2004","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2026.04.005_bib21","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0168-8278(01)00299-9","article-title":"Benign recurrent intrahepatic cholestasis progressing to progressive familial intrahepatic cholestasis: low GGT cholestasis is a clinical continuum","volume":"36","author":"van Ooteghem","year":"2002","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2026.04.005_bib22","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jhep.2020.02.007","article-title":"Genotype correlates with the natural history of severe bile salt export pump deficiency","volume":"73","author":"van Wessel","year":"2020","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2026.04.005_bib23","article-title":"Genotype-phenotype relationships of truncating mutations, p.E297G and p.D482G in bile salt export pump deficiency","volume":"5","author":"Felzen","year":"2023","journal-title":"JHEP Rep"},{"issue":"2","key":"10.1016\/j.cld.2026.04.005_bib24","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/hep.21287","article-title":"Hepatocellular carcinoma in ten children under five years of age with bile salt export pump deficiency","volume":"44","author":"Knisely","year":"2006","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2026.04.005_bib25","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1007\/s10620-025-09431-y","article-title":"Advancing the diagnosis and management of genetic cholestatic liver disease in adults","volume":"71","author":"Nasir","year":"2026","journal-title":"Dig Dis Sci"},{"issue":"1","key":"10.1016\/j.cld.2026.04.005_bib26","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/liv.13186","article-title":"The prevalence of hepatitis C virus infection in Egypt 2015: implications for future policy on prevention and treatment","volume":"37","author":"Kandeel","year":"2017","journal-title":"Liver Int"},{"issue":"3","key":"10.1016\/j.cld.2026.04.005_bib27","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.cld.2022.03.003","article-title":"Overview of progressive familial intrahepatic cholestasis","volume":"26","author":"Hassan","year":"2022","journal-title":"Clin Liver Dis"},{"issue":"10","key":"10.1016\/j.cld.2026.04.005_bib28","article-title":"Outcomes of 38 patients with PFIC3: impact of genotype and of response to ursodeoxycholic acid therapy","volume":"5","author":"Gonzales","year":"2023","journal-title":"JHEP Rep"},{"issue":"14","key":"10.1016\/j.cld.2026.04.005_bib29","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1056\/NEJMoa0901075","article-title":"Recurrence of bile salt export pump deficiency after liver transplantation","volume":"361","author":"Jara","year":"2009","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.cld.2026.04.005_bib30","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1002\/lt.23754","article-title":"Rituximab as therapy for the recurrence of bile salt export pump deficiency after liver transplantation","volume":"19","author":"Lin","year":"2013","journal-title":"Liver Transpl"},{"issue":"7","key":"10.1016\/j.cld.2026.04.005_bib31","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S2468-1253(24)00080-3","article-title":"Maralixibat in progressive familial intrahepatic cholestasis (MARCH-PFIC): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","volume":"9","author":"Miethke","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.cld.2026.04.005_bib32","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/S2468-1253(22)00093-0","article-title":"Odevixibat treatment in progressive familial intrahepatic cholestasis: a randomised, placebo-controlled, phase 3 trial","volume":"7","author":"Thompson","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.cld.2026.04.005_bib33","article-title":"Interim results from an ongoing, open-label, single-arm trial of odevixibat in progressive familial intrahepatic cholestasis","volume":"5","author":"Thompson","year":"2023","journal-title":"JHEP Rep"},{"issue":"5","key":"10.1016\/j.cld.2026.04.005_bib34","doi-asserted-by":"crossref","DOI":"10.1002\/jimd.70081","article-title":"Treatment of inborn errors by product replacement: the example of inborn errors of bile acid synthesis","volume":"48","author":"Clayton","year":"2025","journal-title":"J Inherit Metab Dis"},{"issue":"2","key":"10.1016\/j.cld.2026.04.005_bib35","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3727\/105221618X15156018385515","article-title":"Bile acid metabolism in liver pathobiology","volume":"18","author":"Chiang","year":"2018","journal-title":"Gene Expr"},{"issue":"4","key":"10.1016\/j.cld.2026.04.005_bib36","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1053\/j.gastro.2009.07.043","article-title":"Oral cholic acid for hereditary defects of primary bile acid synthesis: a safe and effective long-term therapy","volume":"137","author":"Gonzales","year":"2009","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.cld.2026.04.005_bib37","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/MPG.0000000000001657","article-title":"Oral cholic acid is efficacious and well tolerated in patients with bile acid synthesis and Zellweger spectrum disorders","volume":"65","author":"Heubi","year":"2017","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"1","key":"10.1016\/j.cld.2026.04.005_bib38","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/MPG.0b013e3181b47b34","article-title":"Variable clinical spectrum of the most common inborn error of bile acid metabolism--3beta-hydroxy-Delta 5-C27-steroid dehydrogenase deficiency","volume":"50","author":"Subramaniam","year":"2010","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"4","key":"10.1016\/j.cld.2026.04.005_bib39","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.cld.2018.06.006","article-title":"Inborn errors of bile acid metabolism","volume":"22","author":"Heubi","year":"2018","journal-title":"Clin Liver Dis"},{"issue":"4","key":"10.1016\/j.cld.2026.04.005_bib40","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1055\/s-0041-1730951","article-title":"Alagille syndrome: a focused review on clinical features, genetics, and treatment","volume":"41","author":"Kohut","year":"2021","journal-title":"Semin Liver Dis"},{"issue":"5","key":"10.1016\/j.cld.2026.04.005_bib41","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1007\/s12072-023-10578-x","article-title":"Management of adults with Alagille syndrome","volume":"17","author":"Ayoub","year":"2023","journal-title":"Hepatol Int"},{"issue":"8","key":"10.1016\/j.cld.2026.04.005_bib42","first-page":"726","article-title":"Heritable chronic cholestatic liver diseases: a review","volume":"12","author":"Tidwell","year":"2024","journal-title":"J Clin Transl Hepatol"},{"issue":"4","key":"10.1016\/j.cld.2026.04.005_bib43","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.cld.2018.06.001","article-title":"Alagille syndrome","volume":"22","author":"Mitchell","year":"2018","journal-title":"Clin Liver Dis"},{"issue":"10311","key":"10.1016\/j.cld.2026.04.005_bib44","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/S0140-6736(21)01256-3","article-title":"Efficacy and safety of maralixibat treatment in patients with Alagille syndrome and cholestatic pruritus (ICONIC): a randomised phase 2 study","volume":"398","author":"Gonzales","year":"2021","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.cld.2026.04.005_bib45","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1002\/hep4.1992","article-title":"Impact of long-term administration of maralixibat on children with cholestasis secondary to Alagille syndrome","volume":"6","author":"Shneider","year":"2022","journal-title":"Hepatol Commun"},{"issue":"7","key":"10.1016\/j.cld.2026.04.005_bib46","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S2468-1253(24)00074-8","article-title":"Efficacy and safety of odevixibat in patients with Alagille syndrome (ASSERT): a phase 3, double-blind, randomised, placebo-controlled trial","volume":"9","author":"Ovchinsky","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2026.04.005_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.704586","article-title":"Therapeutics development for Alagille syndrome","volume":"12","author":"Sanchez","year":"2021","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.cld.2026.04.005_bib48","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1186\/s12964-025-02403-9","article-title":"The primary cilium as a multifunctional organelle: emerging roles and unanswered questions","volume":"23","author":"Corbeil","year":"2025","journal-title":"Cell Commun Signal"},{"issue":"4","key":"10.1016\/j.cld.2026.04.005_bib49","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.clinre.2014.04.001","article-title":"Liver involvement in children with ciliopathies","volume":"38","author":"Rock","year":"2014","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"4","key":"10.1016\/j.cld.2026.04.005_bib50","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.jhep.2022.06.002","article-title":"EASL Clinical Practice Guidelines on the management of cystic liver diseases","volume":"77","year":"2022","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2026.04.005_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/cells12020307","article-title":"The landscape of HNF1B deficiency: a syndrome not yet fully explored","volume":"12","author":"Gambella","year":"2023","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.cld.2026.04.005_bib52","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nrneph.2014.232","article-title":"HNF1B-associated renal and extra-renal disease-an expanding clinical spectrum","volume":"11","author":"Clissold","year":"2015","journal-title":"Nat Rev Nephrol"},{"issue":"4","key":"10.1016\/j.cld.2026.04.005_bib53","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/hep4.1320","article-title":"Recessive mutations in KIF12 cause high gamma-glutamyltransferase cholestasis","volume":"3","author":"Unlusoy","year":"2019","journal-title":"Hepatol Commun"},{"issue":"4","key":"10.1016\/j.cld.2026.04.005_bib54","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/jpr3.12111","article-title":"ZFYVE19 gene mutation: a novel variant of progressive familial intrahepatic cholestasis","volume":"5","author":"Ben Sabbahia","year":"2024","journal-title":"JPGN Rep"},{"issue":"1","key":"10.1016\/j.cld.2026.04.005_bib55","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s13023-021-01775-8","article-title":"A ZFYVE19 gene mutation associated with neonatal cholestasis and cilia dysfunction: case report with a novel pathogenic variant","volume":"16","author":"Mandato","year":"2021","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"10.1016\/j.cld.2026.04.005_bib56","doi-asserted-by":"crossref","DOI":"10.1002\/ajmg.a.63515","article-title":"A novel TTC26 variant in a patient with hexadactyly, pituitary stalk interruption, hepatopathy, nephropathy, and bilateral lip-palate cleft: a case report and expansion of the phenotype","volume":"194","author":"Papingi","year":"2024","journal-title":"Am J Med Genet A"},{"issue":"3","key":"10.1016\/j.cld.2026.04.005_bib57","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000513829","article-title":"Identification of the TTC26 splice variant in a novel complex ciliopathy syndrome with biliary, renal, neurological, and skeletal manifestations","volume":"12","author":"Alfadhel","year":"2021","journal-title":"Mol Syndromol"},{"issue":"3","key":"10.1016\/j.cld.2026.04.005_bib58","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/hep.30515","article-title":"Identification of polycystic kidney disease 1 like 1 gene variants in children with biliary atresia splenic malformation syndrome","volume":"70","author":"Berauer","year":"2019","journal-title":"Hepatology"},{"issue":"18","key":"10.1016\/j.cld.2026.04.005_bib59","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1056\/NEJMra2216474","article-title":"Cystic fibrosis","volume":"389","author":"Grasemann","year":"2023","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"10.1016\/j.cld.2026.04.005_bib60","first-page":"S98","article-title":"Pathophysiology of cystic fibrosis liver disease","volume":"59","author":"Kasper","year":"2024","journal-title":"Pediatr Pulmonol"},{"issue":"5","key":"10.1016\/j.cld.2026.04.005_bib61","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1097\/HEP.0000000000000646","article-title":"Cystic fibrosis screening, evaluation, and management of hepatobiliary disease consensus recommendations","volume":"79","author":"Sellers","year":"2024","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2026.04.005_bib62","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1002\/hep.30148","article-title":"Cystic fibrosis liver disease: outcomes and risk factors in a large cohort of French patients","volume":"69","author":"Boelle","year":"2019","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2026.04.005_bib63","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/MPG.0000000000001728","article-title":"Variceal hemorrhage and adverse liver outcomes in patients with cystic fibrosis cirrhosis","volume":"66","author":"Ye","year":"2018","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"10","key":"10.1016\/j.cld.2026.04.005_bib64","article-title":"Cystic fibrosis liver disease progression in the era of elexacaftor-tezacaftor-ivacaftor","volume":"7","author":"Mouliade","year":"2025","journal-title":"JHEP Rep"},{"issue":"3","key":"10.1016\/j.cld.2026.04.005_bib65","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/hep.32441","article-title":"mRNA and gene editing: late breaking therapies in liver diseases","volume":"76","author":"Zabaleta","year":"2022","journal-title":"Hepatology"},{"issue":"22","key":"10.1016\/j.cld.2026.04.005_bib66","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1056\/NEJMoa2504747","article-title":"Patient-specific in vivo gene editing to treat a rare genetic disease","volume":"392","author":"Musunuru","year":"2025","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.cld.2026.04.005_bib67","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jhep.2019.03.021","article-title":"Liver-directed gene therapy results in long-term correction of progressive familial intrahepatic cholestasis type 3 in mice","volume":"71","author":"Aronson","year":"2019","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2026.04.005_bib68","doi-asserted-by":"crossref","first-page":"5694","DOI":"10.1038\/s41467-019-13614-3","article-title":"Gene therapy for progressive familial intrahepatic cholestasis type 3 in a clinically relevant mouse model","volume":"10","author":"Weber","year":"2019","journal-title":"Nat Commun"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326126000395?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326126000395?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T23:35:14Z","timestamp":1784763314000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326126000395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":68,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S1089326126000395"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2026.04.005","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic Cholestasis Syndromes","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2026.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}